{"id":"W2045950562","doi":"10.1016/s1470-2045(09)70087-7","title":"Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institute for Health and Care Research; GlaxoSmithKline","keywords":"Medicine; Lapatinib; Internal medicine; Breast cancer; Response Evaluation Criteria in Solid Tumors; Oncology; Inflammatory breast cancer; Trastuzumab; Anthracycline; Cohort; Progressive disease; Metastatic breast cancer; Cancer; Refractory (planetary science); Taxane; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001793534,0.0002132185,0.0008348376,0.0001185963,0.0001082649,0.00001180761,0.0003315405,0.0001470496,0.00006269162],"category_scores_gemma":[0.000180474,0.0001135181,0.00003301568,0.000419464,0.0002882096,0.0000822313,0.00009778226,0.0008037238,7.806316e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004892116,"about_ca_system_score_gemma":0.0008560717,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001150616,"about_ca_topic_score_gemma":0.005954369,"domain_scores_codex":[0.9970191,0.0009598585,0.0005948839,0.0003938163,0.0005643815,0.000468025],"domain_scores_gemma":[0.998422,0.0003607049,0.000305572,0.0006916629,0.0001375455,0.00008249694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06819284,0.003050302,0.8744791,0.00004551459,0.00006917744,0.00006635314,0.005372385,0.00002904264,0.0006468978,0.000006823415,0.000575564,0.04746597],"study_design_scores_gemma":[0.05824235,0.009106859,0.9297658,0.0004260856,0.00003158114,0.00001229342,0.0005324653,0.00005765484,0.0001133689,0.00002682378,0.00155858,0.0001261587],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931703,0.000123427,7.803016e-7,0.003733417,0.0001135068,0.002004044,0.00007584815,0.00002282214,0.0007559094],"genre_scores_gemma":[0.9986237,0.0002200012,0.00005588522,0.000551856,0.0001880682,0.0001375243,0.000007468698,0.00002569771,0.0001898218],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05528665,"threshold_uncertainty_score":0.4629134,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0591464160017507,"score_gpt":0.4011642093019165,"score_spread":0.3420177933001658,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}